REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/18/2026
Back to search
Official data from USPTO
CELL SOURCE MATTERS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELL SOURCE MATTERS
ST13
US500000088980976Class
42, 44
Filing
88980976
Registration
6357665
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
05/19/2026
Trademark type
Word
Nice classes
42, 44
Filing date
10/04/2018
Registration date
05/18/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/18/2021
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/25/2019
First use in commerce
07/25/2019
Drawing code
4
Owner type
03
Owner location
Philadelphia, PA, US
Examiner
RATCLIFFE, ROBERT L
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc.
Representatives
Caitlin R. Byczko BARNES & THORNBURG LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
pharmaceutical researchdrug discoverydrug development services; medical and scientific research in the field of cancer and oncological disorders; research and development of pharmaceutical preparations for the prevention and treatment of cancer; development of new products for the prevention and treatment of cancer; providing a website featuring medical and scientific research information in the field of pharmaceutical preparations for the prevention and treatment of cancer
Class 44
Providing a website featuring medical information in the field of pharmaceutical preparations for the prevention and treatment of cancer
Publications
History of USPTO decisions and trademark events.
48 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/18/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/13/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/11/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/16/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/15/2021
EX1G
SOU EXTENSION 1 GRANTED
03/15/2021
DPCC
DIVISIONAL PROCESSING COMPLETE
03/15/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/11/2021
IUAF
USE AMENDMENT FILED
12/14/2020
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
12/14/2020
EISU
TEAS STATEMENT OF USE RECEIVED
12/14/2020
EXT1
SOU EXTENSION 1 FILED
12/10/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/10/2020
DRRR
DIVISIONAL REQUEST RECEIVED
11/03/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/23/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/28/2020
PUBO
PUBLISHED FOR OPPOSITION
04/28/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/23/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
03/20/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/20/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
03/20/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/20/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/17/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/17/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/17/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/07/2020
GNFR
FINAL REFUSAL E-MAILED
01/07/2020
CNFR
FINAL REFUSAL WRITTEN
01/07/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/19/2019
ALIE
ASSIGNED TO LIE
12/18/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/18/2019
GNSL
LETTER OF SUSPENSION E-MAILED
05/18/2019
CNSL
SUSPENSION LETTER WRITTEN
05/18/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/17/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/16/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/16/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/24/2019
GNRT
NON-FINAL ACTION E-MAILED
01/24/2019
CNRT
NON-FINAL ACTION WRITTEN
01/24/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
01/23/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/23/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
01/23/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/23/2019
DOCK
ASSIGNED TO EXAMINER
01/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/12/2018
NWAP
NEW APPLICATION ENTERED
10/08/2018
Continuous trademark protection
Get notified about every new filing that threatens CELL SOURCE MATTERS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.